
Genetic Signatures Ltd
ASX:GSS

Genetic Signatures Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.31
0.75
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Genetic Signatures Ltd hold over its rivals?
What risks and challenges
does Genetic Signatures Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Genetic Signatures Ltd.
Provide an overview of the primary business activities
of Genetic Signatures Ltd.
What unique competitive advantages
does Genetic Signatures Ltd hold over its rivals?
What risks and challenges
does Genetic Signatures Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Genetic Signatures Ltd.
Provide P/S
for Genetic Signatures Ltd.
Provide P/E
for Genetic Signatures Ltd.
Provide P/OCF
for Genetic Signatures Ltd.
Provide P/FCFE
for Genetic Signatures Ltd.
Provide P/B
for Genetic Signatures Ltd.
Provide EV/S
for Genetic Signatures Ltd.
Provide EV/GP
for Genetic Signatures Ltd.
Provide EV/EBITDA
for Genetic Signatures Ltd.
Provide EV/EBIT
for Genetic Signatures Ltd.
Provide EV/OCF
for Genetic Signatures Ltd.
Provide EV/FCFF
for Genetic Signatures Ltd.
Provide EV/IC
for Genetic Signatures Ltd.
Show me price targets
for Genetic Signatures Ltd made by professional analysts.
What are the Revenue projections
for Genetic Signatures Ltd?
How accurate were the past Revenue estimates
for Genetic Signatures Ltd?
What are the Net Income projections
for Genetic Signatures Ltd?
How accurate were the past Net Income estimates
for Genetic Signatures Ltd?
What are the EPS projections
for Genetic Signatures Ltd?
How accurate were the past EPS estimates
for Genetic Signatures Ltd?
What are the EBIT projections
for Genetic Signatures Ltd?
How accurate were the past EBIT estimates
for Genetic Signatures Ltd?
Compare the revenue forecasts
for Genetic Signatures Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Genetic Signatures Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Genetic Signatures Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of Genetic Signatures Ltd compared to its peers.
Compare the P/E ratios
of Genetic Signatures Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing Genetic Signatures Ltd with its peers.
Analyze the financial leverage
of Genetic Signatures Ltd compared to its main competitors.
Show all profitability ratios
for Genetic Signatures Ltd.
Provide ROE
for Genetic Signatures Ltd.
Provide ROA
for Genetic Signatures Ltd.
Provide ROIC
for Genetic Signatures Ltd.
Provide ROCE
for Genetic Signatures Ltd.
Provide Gross Margin
for Genetic Signatures Ltd.
Provide Operating Margin
for Genetic Signatures Ltd.
Provide Net Margin
for Genetic Signatures Ltd.
Provide FCF Margin
for Genetic Signatures Ltd.
Show all solvency ratios
for Genetic Signatures Ltd.
Provide D/E Ratio
for Genetic Signatures Ltd.
Provide D/A Ratio
for Genetic Signatures Ltd.
Provide Interest Coverage Ratio
for Genetic Signatures Ltd.
Provide Altman Z-Score Ratio
for Genetic Signatures Ltd.
Provide Quick Ratio
for Genetic Signatures Ltd.
Provide Current Ratio
for Genetic Signatures Ltd.
Provide Cash Ratio
for Genetic Signatures Ltd.
What is the historical Revenue growth
over the last 5 years for Genetic Signatures Ltd?
What is the historical Net Income growth
over the last 5 years for Genetic Signatures Ltd?
What is the current Free Cash Flow
of Genetic Signatures Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for Genetic Signatures Ltd.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
AU |
![]() |
Genetic Signatures Ltd
ASX:GSS
|
71.5m AUD | -2 | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 1 236.6 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
187.1B USD | 21.7 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
151.5B USD | 23.2 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
71.2T KRW | 31.1 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
40B CHF | 39.7 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
263.7B CNY | 20.5 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
33.8B USD | 19.6 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
32.6B USD | 13.2 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
27.2B USD | 23.8 |
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
17.5B EUR | 26.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
AU |
![]() |
Genetic Signatures Ltd
ASX:GSS
|
Average EV/EBITDA:
145.6
|
N/A | N/A | |
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1 236.6
|
6%
|
206.1 |
|
US |
![]() |
Thermo Fisher Scientific Inc
NYSE:TMO
|
21.7
|
5%
|
4.3 |
|
US |
![]() |
Danaher Corp
NYSE:DHR
|
23.2
|
7%
|
3.3 |
|
KR |
![]() |
Samsung Biologics Co Ltd
KRX:207940
|
31.1
|
17%
|
1.8 |
|
CH |
![]() |
Lonza Group AG
SIX:LONN
|
39.7
|
18%
|
2.2 |
|
CN |
![]() |
WuXi AppTec Co Ltd
SSE:603259
|
20.5
|
24%
|
0.9 |
|
US |
![]() |
Agilent Technologies Inc
NYSE:A
|
19.6
|
10%
|
2 |
|
US |
![]() |
IQVIA Holdings Inc
NYSE:IQV
|
13.2
|
8%
|
1.6 |
|
US |
![]() |
Mettler-Toledo International Inc
NYSE:MTD
|
23.8
|
4%
|
6 |
|
FR |
![]() |
Sartorius Stedim Biotech SA
PAR:DIM
|
26.5
|
20%
|
1.3 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.